Hydroxychloroquine for Early COVID Studies: Participants Needed

The following is a list of studies using Hydroxychloroquine for early COVID disease compiled from ClinicalTrials.gov on April 24, 2020.

Studies using Hydroxy + Azithromycin:

• Rutgers, The State University of New Jersey
  Hydroxy + Zith vs Hydroxy alone vs. no treatment
  PCR + with T 100.6 or more
  Inpatient or outpatient
  Recruiting
• LCMC Health (New Orleans)
  Hydroxy + azith vs. hydroxy alone vs supportive
  Early disease (<7 days of symptoms, PCR +) in 2 groups-
  Early moderate (O2 sat 94+) to severe disease (O2 sat<94)
  Viral load and clinical
  Recruiting

Hydroxy only studies (without azithro):

• ProgenaBiome (CA-based PCR lab)
  Pre-exposure in health care workers
  Hydroxy + vite C + vite D = Zinc vs. no treatment- no doses listed
• Baylor
  Hydroxy only
  Pre-exposure professional healthcare workers
  PCR q wk X 7; weeks, enroll by invitation
• Elizabeth Oelsner, Columbia University
  Hydroxy only; placebo-controlled
  Post-exposure professional to housemates
  Not yet recruiting
• Hackensack Meridian Health
  Hydroxy only, open-label, no placebo
  Pre-exposure professional health care workers
• Washington University School of Medicine
  Hydroxy only- testing 3 different doses
  Pre-exposure; healthcare workers
  Not yet recruiting
• University of Minnesota
  McGill University Health Centre/Research Institute of the McGill University Health Centre
  University of Manitoba
  University of Alberta
  Exposure or early disease <4 days of symptoms
  Hydroxy only vs. Placebo
  Recruiting
• Montefiore Medical Center
  Early disease, confirmed + or suspect
  Hydroxy only
  Not yet recruiting
• Providence Health & Services
  Hydroxy vs. Vitamin C
  Early disease- outpatients, PCR + By invitation
• GeoSentinel Foundation
  Pre-exposure professional health care workers
  Hydroxy vs. placebo
  Not yet recruiting

Thank You Joseph Burrascano, MD for compiling this reference list.

Disclaimer: The Lyme Disease Association Inc. (LDA) provides this information as a public service. LDA does not necessarily endorse any of the studies or recommend participation in any studies. Participants need to review the information on the studies and make their own decisions regarding participation.